Biodesix (BDSX) Short term Debt (2021 - 2024)

Biodesix (BDSX) has reported Short term Debt for 4 consecutive years, with $5.8 million the latest figure, recorded in Q2 2024.

• Short term Debt for Q2 2024 came in at $5.8 million, down 59.91% year-over-year; the trailing twelve-month figure through Jun 2024 was $5.8 million (down 59.91% YoY), and the FY2023 annual result was $21.9 million, up 111.36% from the prior year.
• Short term Debt was $5.8 million for Q2 2024 at Biodesix, down from $19.2 million in the prior quarter.
• Over five years, Short term Debt peaked at $21.9 million in Q4 2023 and troughed at $5.8 million in Q2 2024.
• Average Short term Debt over 4 years is $13.7 million, with a median of $13.1 million recorded in 2021.
• Year-over-year, Short term Debt soared 111.36% in 2023 and slumped 59.91% in 2024.
• Over 4 years, Short term Debt stood at $17.8 million in 2021, then slumped by 41.79% to $10.3 million in 2022, then jumped by 111.36% to $21.9 million in 2023, then slumped by 73.29% to $5.8 million in 2024.
• Per Business Quant data, the three most recent Short term Debt figures were $5.8 million in Q2 2024, $19.2 million in Q1 2024, and $21.9 million in Q4 2023.